Aesku.Group GmbH products

HELIA® is an automated analyzer for line immunoassays. The HELIA system is able to perform all immunoblot processing steps, and due to an integrated camera module, it is able to read and report immunoblot results. The HELMED® processor architecture, and the HELIA® system unites proven lab automation with innovative immunoblot processing and reading technology. HELIA® was developed to simplify and automate immunoblot testing with a focus on standardization, minimal footprint and easy implementation. HELIA® includes a pre-installed and configured space-saving All-in-one PC. AESKU develops, designs and produces the HELIA® system and all dedicated reagents, offering complete control of the entire product life cycle.

The AESKU.RAPID SARS-CoV-2 Rapid Test is based on immunochromatographic polymer technology combined with the sandwich principle for the qualitative detection of the nucleocapsid protein antigen in human nasal swab specimens. The specimen is placed in the test device`s specimen well with colored polymer-labeled monoclonal SARS-CoV-2 antibody 1 and mixed along the nitrocellulose membrane chromatographed. If SARS-CoV-2 antigens are present in the sample, they bind to the SARS-CoV-2 antibody 1.The mixture then binds to the immobilized SARS-CoV-2 antibody 2 on the nitrocellulose membrane. The resulting complex of antibody 1, antigen, and antibody 2 forms the colored test line. The test device`s control line is coated with secondary antibodies, which, under normal test procedure, a colored strip is drawn.

AESKULISA for qualitative and quantitative demonstration of IgA, IgG, or IgM antibodies directed against a range of different pathogens supporting a reliable diagnosis of infectious diseases.

The AESKUBLOTS test line represents a variety of different immunoblots for an effcient sample testing of autoimmune and infectious diseases.

The AESKUBLOTS test line represents a variety of different immunoblots for an effcient sample testing of autoimmune and infectious diseases.